))
Battling Emerging Viruses with Anu Osinusi
Manage episode 343793852 series 2793902
Breaking Media에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Breaking Media 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
For today’s episode, I interviewed Anu Osinusi, Vice President of Clinical Research for Hepatitis, Respiratory and Emerging Viruses at Gilead. She talks about how Gilead is at the forefront of battling viral diseases as well as the solutions they are formulating to ensure that each and every person has access to treatments for future pandemics and to preserve global health across the globe.
Who’s The Guest? Anu Osinusi serves as the Vice President of Clinical Development at Gilead Sciences. As a clinician-researcher with more than 15 years of experience in drug development, liver diseases, infectious diseases, and global health, she is responsible for overseeing the Viral Hepatitis (Hep B, C, and D), Respiratory and Emerging (COVID-19, Ebola, RSV, and others) Viruses portfolio.
Episode Sponsored By Gilead
Episode Resources
- Connect with Arundhati Parmar
- [email protected]
- https://twitter.com/aparmarbb?lang=en
- https://medcitynews.com/
- Connect with Anu Osinusi
- https://www.gilead.com/
- https://www.linkedin.com/in/anu-osinusi-aoo
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
72 에피소드
공유
